Plant molecular farming (PMF) is a new branch of plant biotechnology, where plants are
engineered to produce recombinant pharmaceutical and industrial proteins in large …

“Molecular farming” in plants with significant advantages in cost and safety is touted as a
promising platform for the production of complex pharmaceutical proteins. While whole-plant …

In recent years, the use of plants as bioreactors has emerged as an exciting area of research
and significant advances have created new opportunities. The driving forces behind the …

Numerous reports have been published over the last decade assessing the potential of
plants as useful hosts for the heterologous expression of clinically useful proteins …

In the molecular farming area, transient expression approaches for pharmaceutical proteins
production, mainly recombinant monoclonal antibodies and vaccines, were developed …

Plants have been identified as promising expression systems for commercial production of
vaccine antigens. In phase I clinical trials several plant-derived vaccine antigens have been …

Insufficient accumulation levels of recombinant proteins in plants and the lack of efficient
purification methods for recovering these valuable proteins have hindered the development …

Plant cell culture is emerging as an alternative bioproduction system for recombinant
pharmaceuticals. Growing plant cells in vitro under controlled environmental conditions …

For the past two decades, therapeutic and industrially important proteins have been
expressed in plants with varying levels of success. The two major challenges hindering the …

Plant-based transient overexpression systems enable rapid and scalable production of
subunit vaccines. Previously, we have shown that cholera toxin B subunit (CTB), an oral …